Baytril 2.5% injection solution 100ml

DESCRIPTION

Baytril 2.5% is a drug for the treatment of dogs and cats with diseases of bacterial and mycoplasma etiology.

COMPOSITION

1 ml of injection solution contains 25 mg of enrofloxacin as an active ingredient and auxiliary components: potassium hydroxide, n-butanol, water for injection.

PHARMACOLOGICAL PROPERTIES

Enrofloxacin, which is part of the drug, belongs to the group of fluoroquinolones, has a wide spectrum of antibacterial and antimycoplasmic action, inhibits the growth and development of gram-positive and gram-negative bacteria, including Escherichia, hemophilus, Salmonella, Pasteurella, Staphylococcus, Streptococcus, Streptococcus bordetella, campylobacter, corynebacterium, proteus, and also mycoplasma. The mechanism of action of enrofloxacin is to inhibit the activity of the enzyme gyrase, which affects the replication of the DNA helix in the nucleus of a bacterial cell. When administered parenterally, enrofloxacin is well and quickly absorbed from the injection site and penetrates into all organs and tissues of the body. The maximum concentration of enrofloxacin in the blood is reached after 20-40 minutes,

Baytril 2.5% solution for injection according to the degree of effect on the body refers to moderately hazardous substances, in recommended doses it is well tolerated by animals, does not have embryotoxic, teratogenic and hepatotoxic effects. Enrofloxacin is excreted from the body mainly unchanged, partially metabolized to ciprofloxacin and excreted in urine and feces.

INDICATIONS

Prescribed to dogs and cats with a therapeutic purpose in diseases of the respiratory system, gastrointestinal tract, genitourinary system, septicemia, colibacillosis, salmonellosis, streptococcosis and other diseases caused by microorganisms sensitive to fluoroquinolones, as well as mixed and secondary infections.

APPLICATION

Baytril 2.5% injection solution is administered to dogs and cats subcutaneously or intramuscularly at a dose of 0.2 ml per 1 kg of animal weight (5 mg of enrofloxacin per 1 kg of weight) once a day for 3 to 10 days. Due to the possible painful reaction, the drug should not be administered to the animal in one place in a volume exceeding 2.5 ml.

If no noticeable clinical improvement occurs within 3 - 5 days, it is recommended to retest for the sensitivity of microorganisms isolated from a sick animal to fluoroquinolones or replace Baytril with another antibacterial drug.

SIDE EFFECTS

In some cases, a short-term dysfunction of the gastrointestinal tract is possible. Redness may occur at the injection point, which disappears spontaneously.

CONTRAINDICATIONS

Hypersensitivity to enrofloxacin and other quinolones. It is forbidden to prescribe to females during pregnancy and lactation, with significant disorders in the development of cartilage tissue, lesions of the nervous system, accompanied by convulsions, as well as when microorganisms resistant to fluoroquinolones are isolated from a sick animal. The simultaneous use of Baytril with chloramphenicol, macrolides, tetracyclines, theophylline and non-steroidal anti-inflammatory drugs is not allowed.

It is advisable not to apply to puppies and kittens until the end of their growth period.

STORAGE

Store in a dry, dark place, out of reach of children and animals, at a temperature of 5 В° C to 25 В° C. The shelf life is 3 years. After opening the bottle, the drug can be used within 28 days.

PACKING

Produced in dark glass bottles of 100 ml, which are packed in cardboard boxes.

Specifications

KolVUP

40

Manufacturer

Bayer

Teaser

for diseases of the respiratory system, gastrointestinal tract, genitourinary system, septicemia, colibacillosis, salmonellosis, streptococcosis and other diseases caused by microorganisms